Regulatory Insights

  1. Advancing IHC Assays From RUO To Clinical Trials And CDx 8/21/2026

    Examine how an exploratory IHC assay evolved into a multi-indication clinical program through integrated assay development, validation, regulatory strategy, and scientific collaboration.

  2. PMCF Requirements: Questions On Cost, Device Viability, And Where AI Fits In 8/20/2026

    PMCF costs are straining device budgets. Discover how AI-assisted review and real-world data from other regions can help you meet EU requirements more efficiently.

  3. Operationalizing Global Oncology Trials: Fast-Track Development Timelines 8/20/2026

    Running oncology trials across multiple regions? Learn how coordinated planning, oversight, and expertise keep complex studies on track from start to registration.

  4. Scaling Investigational Drug Services: A Case Study in Overcoming Operational Bottlenecks 8/20/2026

    Are operational bottlenecks holding back your research site? Explore a blueprint for automating investigational product workflows and giving staff time back for patient care.

  5. Under Half Of CTIS Trials Met Results Reporting Requirements 8/14/2026

    A first assessment of compliance on EU Clinical Trial Information System (CTIS) found fewer than half of European Phase II–IV drug trials legally required to post results fully complied on time.

  6. The Regulatory Compass Driving Drug Delivery Innovation 8/12/2026

    Regulatory requirements are growing more complex. Discover how strategic planning, regulatory intelligence, and platform approaches can streamline development and approvals.

  7. MIDBA: A New Regulatory Approach To Clinical Device Bridging 8/12/2026

    When devices evolve, evidence expectations can shift. Explore a risk-based clinical bridging approach to support regulatory decisions.

  8. Matching Pharmacovigilance Methodology To Organizational Scale 8/12/2026

    One-size-fits-all doesn't work for safety signal detection. Discover a scalable framework that keeps expert judgment at the center — no matter how large your portfolio grows.

  9. Clinical Supply Flexibility Where Biotech Programs Need It Most 8/10/2026

    Flexible clinical development requires scalable infrastructure, strong project management, and global logistics to ensure supply continuity and regulatory compliance.

  10. Packaging And Labeling Support For A Global Cell Therapy Program 8/10/2026

    Master complex cell therapy logistics with coordinated depots, purpose-built labeling, and temperature-controlled solutions that protect product integrity.